30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Smith+Nephew CEO Stepping Down -

Smith+Nephew CEO Namal Nawana will step down from his position on October 31, by mutual agreement, to pursue opportunities outside of the U.K. Roland Diggelmann will become SNN’s new CEO on November 1. His previous leadership role was CEO of Roche Diagnostics, which reported revenue of $11.5 billion in 2018. Mr. Diggelmann’s 11 years at Roche were preceded by 12 years in orthopedics at Sulzer Orthopedics and Zimmer. Mr. Diggelmann joined SNN’s board as a non-executive director in early 2018. Under Mr. Nawana’s stewardship from May 2018 to October 2019, SNN averaged growth of 1.5% per quarter, driven mostly by knee replacement and sports medicine sales. (Smith+Nephew, 10/21/19)